Image
Loading
Image
30 August, 2019

Understanding Immunotherapy

Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body’s natural defenses to fight cancer. It uses substances made by the body or in a […]

Read More
Image
29 August, 2019

How is Immunotherapy Changing the Outlook for Patients with Breast Cancer?

Breast cancer is one of the most commonly diagnosed cancer types among women globally. Globally, there were an estimated 2.1 million new cases of breast cancer and 630,000 deaths due […]

Read More
Image
8 August, 2019

Genetic testing and personalisation: weapons against cancer!

In a rapidly developing technological age, a deeper knowledge of the biology of a person’s body enables a personalised approach to a variety of diseases, such as cancer, giving a […]

Read More
Image
24 April, 2019

25th of April – Celebrating DNA Day!

We celebrate today The National Day of DNA,  going back to the 25th of April 1953, when the first articles about DNA structure were published by James Watson, Francis Crick, […]

Read More
Image
24 April, 2019

Gene Analysis – “Today’s weapon, tomorrow’s victory”

World DNA Day was established and is celebrated on 25 April each year as it was on this date in 1953 that biologists Francis Crick and James Watson published their […]

Read More
Image
22 April, 2019

Risk Assessment for Legacy Cancer: “Your genes speak, we just translate!”

Genekor performs gene analyses that have been developed according to the latest technological standards and strictly following the existing international scientific guidelines. Hereditary predisposition to cancer is found in about […]

Read More
Image
12 March, 2019

Immunotherapy: The great hope for curing cancer

Immunotherapies have been familiar to the field of medicine for decades, yet in recent years through parallel rapid progress in the field of molecular biology they have become a pillar […]

Read More
Image
21 February, 2019

ASBrS Calls for Genetic Testing for All Breast Cancer Patients

The American Society of Breast Surgeons (ASBrS) is calling for all patients with breast cancer to be offered genetic testing and to not restrict such tests only to patients at highest risk for […]

Read More
Image
19 February, 2019

Landmark TAILORx study results make the Oncotype DX Breast Recurrence Score® Assay the new Standard of Care.

Breast cancer is the most common type of cancer in women worldwide. Hormone-receptor-positive, axillary node-negative disease accounts for approximately half of all cases of breast cancer in general.  Most of […]

Read More